How many institutional investors hold CLGN?

1 tracked institutional investor disclosed a position in CLGN (COLLPLANT BIOTECHNOLOGIES LT) in their most recent 13F filing.

Who is the largest institutional holder of CLGN?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in CLGN, valued at $17,211.

Did institutional ownership of CLGN increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited CLGN.

Where does this CLGN ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CLGN — COLLPLANT BIOTECHNOLOGIES LT

Name: COLLPLANT BIOTECHNOLOGIES LT (CLGN) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About COLLPLANT BIOTECHNOLOGIES LT (CLGN)

COLLPLANT BIOTECHNOLOGIES LT (CLGN) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $17,211. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CLGN

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track CLGN

/100

Undiscovered

1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded

151015+

CLGN Ownership Composition

How COLLPLANT BIOTECHNOLOGIES LT is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

100% of tracked value

Institutions

tracked investors

Total Reported

$17.2K

combined 13F value

Other100.0%

Other(1)

100.0%

Tracked investors reporting CLGN

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	32.2K	$17.2K	0.00%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
32.2K
Value
$17.2K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold CLGN?: 1 tracked institutional investor disclosed a position in CLGN (COLLPLANT BIOTECHNOLOGIES LT) in their most recent 13F filing.
Who is the largest institutional holder of CLGN?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in CLGN, valued at $17,211.
Did institutional ownership of CLGN increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited CLGN.
Where does this CLGN ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.